Resultados de la búsqueda 561-570 of 12647 for Raised prolactin

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

2. Neurología - Ensayos clínicos - Mayo Clinic

   ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

3. Neurología - Ensayos clínicos - Mayo Clinic

   ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... high risk of recurrence based on histological interpretation of the ILND specimen. Patients at high risk of relapse are eligible for InPACT-pelvis, where ...

5. Ensayos clínicos - Neurología

   Multiscale EEG Dynamics · Dominantly Inherited Alzheimer Network (DIAN) · Cerebrospinal Fluid Biomarkers For Brain Tumors · Acute Modulation of Stereotyped High- ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

8. Síndrome de Prader-Willi

   Butler MG, et al. Prader-Willi syndrome ⸺ Clinical genetics, diagnosis and treatment approaches: An update. Current Pediatric Reviews. 2019; doi:10.2174/ ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

10. Neurología - Ensayos clínicos - Mayo Clinic

    ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...